Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
1992-11-4
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0040-5957
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
47
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
125-6
|
| pubmed:dateRevised |
2006-10-30
|
| pubmed:meshHeading |
pubmed-meshheading:1412138-Arteriosclerosis Obliterans,
pubmed-meshheading:1412138-Humans,
pubmed-meshheading:1412138-Intermittent Claudication,
pubmed-meshheading:1412138-Magnetic Resonance Spectroscopy,
pubmed-meshheading:1412138-Muscles,
pubmed-meshheading:1412138-Phosphorus,
pubmed-meshheading:1412138-Vasodilator Agents
|
| pubmed:articleTitle |
Assessment of the efficacy of vasodilator drugs in peripheral vascular disease through a study of skeletal muscle metabolism using 31P nuclear magnetic resonance (NMR) spectroscopy.
|
| pubmed:publicationType |
Letter
|